Central neurotensin protects the mucosa by a prostaglandin-mediated mechanism and inhibits gastric acid secretion in the rat.
Kauffman
G L
GL
Department of Surgery, Pennsylvania State University College of Medicine, Milton S. Hershey Medical Center, Hershey 17033.
Zhang
L
L
Xing
L P
LP
Seaton
J
J
Colony
P
P
Demers
L
L
D000818:Animals; D001921:Brain / Q000502:physiology*; D003080:Cold Temperature / Q000009:adverse effects; D018492:Dopamine Antagonists; D005744:Gastric Acid / Q000378:metabolism*; D005753:Gastric Mucosa / Q000098:blood supply / Q000378:metabolism / Q000473:pathology; D007101:Immersion / Q000009:adverse effects; D007275:Injections, Intravenous; D007276:Injections, Intraventricular; D008297:Male; D009496:Neurotensin / Q000097:blood / Q000494:pharmacology / Q000502:physiology*; D010418:Pentagastrin / Q000494:pharmacology; D011453:Prostaglandins / Q000378:metabolism / Q000502:physiology*; D051381:Rats; D011919:Rats, Inbred Strains; D012039:Regional Blood Flow / Q000187:drug effects; D012149:Restraint, Physical / Q000009:adverse effects
D018492:Dopamine Antagonists; D011453:Prostaglandins; D009496:Neurotensin; D010418:Pentagastrin